NAPIGEN, INC.
PrivateLast Round
Grant
Mar 11, 2024
Total Funding Raised
$9.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NAPIGEN, INC. is a biotechnology and AgTech company that provides novel genome engineering of organisms such as plants, microbes, and animals by targeting cellular components known as mitochondria and chloroplasts.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NAPIGEN, INC. Comparables
Compare NAPIGEN, INC. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plastomics, Inc. | 81% | |
| Cibus, Inc. | 63% | |
| Inari | 61% |
NAPIGEN, INC. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2024 | ||||
| Series A | Mar 11, 2024 | ||||
| Seed | Jul 12, 2022 | ||||
| Grant | May 14, 2020 | ||||
| Grant | Jan 1, 2020 | ||||
Grant | Dec 12, 2019 |
NAPIGEN, INC. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SVG Ventures|THRIVE | Seed, Accelerator |
| RA Capital Management | Seed |
| Thiel Foundation | Seed |
| NIH RADx | Grant |
| United Mitochondrial Disease Foundation | Seed, Grant |
| The Grantham Foundation for the Protection of the Environment | Seed |
| Delaware Division of Small Business | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 77% MoM.
- Mar 11, 2024
$175K grant from the U.S. Department of Agriculture.
NAPIGEN, INC. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NAPIGEN, INC.'s valuation, stock price, and market status.
Is NAPIGEN, INC. a public or private company?
NAPIGEN, INC. is a private company.
What is the current stock price of NAPIGEN, INC.?
NAPIGEN, INC. is a private company, so its shares have no public market price. Caplight tracks NAPIGEN, INC.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NAPIGEN, INC. worth (valuation)?
Valuation information for NAPIGEN, INC. is not publicly available.
Can I buy NAPIGEN, INC. stock?
NAPIGEN, INC. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NAPIGEN, INC.'s last funding round?
NAPIGEN, INC.'s most recent funding round was Grant on March 11, 2024.
Who are the main investors in NAPIGEN, INC.?
Key investors in NAPIGEN, INC. include RA Capital Management, The Grantham Foundation for the Protection of the Environment.
Will NAPIGEN, INC. IPO soon?
No public IPO plans have been announced for NAPIGEN, INC..
How can I track NAPIGEN, INC. secondary market activity?
Caplight tracks bids, offers, and trades in NAPIGEN, INC.'s shares on secondary markets.